267 related articles for article (PubMed ID: 23796235)
1. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
Russell JA; Fjell C; Hsu JL; Lee T; Boyd J; Thair S; Singer J; Patterson AJ; Walley KR
Am J Respir Crit Care Med; 2013 Aug; 188(3):356-64. PubMed ID: 23796235
[TBL] [Abstract][Full Text] [Related]
2. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
3. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
5. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
[TBL] [Abstract][Full Text] [Related]
7. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
Anantasit N; Boyd JH; Walley KR; Russell JA
Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
[TBL] [Abstract][Full Text] [Related]
8. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
9. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
[TBL] [Abstract][Full Text] [Related]
10. Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine.
Mehta S; Granton J; Gordon AC; Cook DJ; Lapinsky S; Newton G; Bandayrel K; Little A; Siau C; Ayers D; Singer J; Lee TC; Walley KR; Storms M; Cooper DJ; Holmes CL; Hebert P; Presneill J; Russell JA;
Crit Care; 2013 Jun; 17(3):R117. PubMed ID: 23786655
[TBL] [Abstract][Full Text] [Related]
11. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
12. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
He X; Su F; Taccone FS; Laporte R; Kjølbye AL; Zhang J; Xie K; Moussa MD; Reinheimer TM; Vincent JL
Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
14. Bench-to-bedside review: Vasopressin in the management of septic shock.
Russell JA
Crit Care; 2011 Aug; 15(4):226. PubMed ID: 21892977
[TBL] [Abstract][Full Text] [Related]
15. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
17. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin and its immune effects in septic shock.
Russell JA; Walley KR
J Innate Immun; 2010; 2(5):446-60. PubMed ID: 20606409
[TBL] [Abstract][Full Text] [Related]
19. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
20. The effects of vasopressin on acute kidney injury in septic shock.
Gordon AC; Russell JA; Walley KR; Singer J; Ayers D; Storms MM; Holmes CL; Hébert PC; Cooper DJ; Mehta S; Granton JT; Cook DJ; Presneill JJ
Intensive Care Med; 2010 Jan; 36(1):83-91. PubMed ID: 19841897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
